AAPL335.29+8.72 (+2.67%) ▲|ABBV256.43+1.43 (+0.56%) ▲|ABT101.74-1.62 (-1.57%) ▼|ACN180.17+2.26 (+1.27%) ▲|ADBE248.03-0.80 (-0.32%) ▼|AMAT463.70+9.69 (+2.13%) ▲|AMD517.08+13.48 (+2.68%) ▲|AMGN379.96-2.52 (-0.66%) ▼|AMT178.28+5.30 (+3.06%) ▲|AMZN255.90+4.01 (+1.59%) ▲|AVGO365.67+4.84 (+1.34%) ▲|AXP323.95+3.24 (+1.01%) ▲|BA209.03+4.23 (+2.07%) ▲|BAC62.77+0.21 (+0.34%) ▲|BKNG173.69-0.22 (-0.13%) ▼|BLK1,086.15+23.75 (+2.24%) ▲|BMY63.33-0.42 (-0.66%) ▼|BNY162.95+0.36 (+0.22%) ▲|BRK-B506.99-0.01 (0.00%) ▼|C138.49-0.01 (-0.01%) ▼|CAT821.43+16.43 (+2.04%) ▲|CL87.17-0.73 (-0.83%) ▼|CMCSA25.26+0.09 (+0.34%) ▲|COF207.32+0.21 (+0.10%) ▲|COP136.06-0.98 (-0.72%) ▼|COST903.31+0.93 (+0.10%) ▲|CRM248.33+5.33 (+2.19%) ▲|CSCO111.88+4.44 (+4.13%) ▲|CVS94.04-1.26 (-1.32%) ▼|CVX213.71+0.95 (+0.44%) ▲|DE685.84+7.90 (+1.17%) ▲|DHR200.47-0.07 (-0.03%) ▼|DIS106.92+1.10 (+1.04%) ▲|DUK119.38+0.01 (+0.01%) ▲|EMR150.99+2.62 (+1.77%) ▲|FDX311.14-0.66 (-0.21%) ▼|GD354.17-0.09 (-0.02%) ▼|GE323.91-0.25 (-0.08%) ▼|GEV951.57+27.66 (+2.99%) ▲|GILD143.66-1.15 (-0.79%) ▼|GM85.96-0.16 (-0.19%) ▼|GOOG338.74+8.35 (+2.53%) ▲|GOOGL341.70+9.10 (+2.74%) ▲|GS1,028.20+8.43 (+0.83%) ▲|HD309.33+3.64 (+1.19%) ▲|HON202.77+0.59 (+0.29%) ▲|IBM238.28+4.26 (+1.82%) ▲|INTC103.53+3.21 (+3.20%) ▲|INTU318.93+6.16 (+1.97%) ▲|ISRG367.64+7.18 (+1.99%) ▲|JNJ266.62+0.27 (+0.10%) ▲|JPM356.65+3.09 (+0.87%) ▲|KO88.00+0.17 (+0.19%) ▲|LIN464.70+3.08 (+0.67%) ▲|LLY1,120.39-2.62 (-0.23%) ▼|LMT524.42-5.71 (-1.08%) ▼|LOW197.49+0.90 (+0.46%) ▲|LRCX301.58+3.57 (+1.20%) ▲|MA567.37+2.00 (+0.35%) ▲|MCD252.95-0.10 (-0.04%) ▼|MDLZ62.27-0.20 (-0.32%) ▼|MDT90.38-1.24 (-1.35%) ▼|META653.25+8.87 (+1.38%) ▲|MMM163.88+1.02 (+0.62%) ▲|MO68.84+0.05 (+0.07%) ▲|MRK144.37-0.34 (-0.24%) ▼|MS213.45+0.79 (+0.37%) ▲|MSFT496.15+3.71 (+0.75%) ▲|MU978.44+1.03 (+0.11%) ▲|NEE82.37-0.07 (-0.08%) ▼|NFLX76.84+0.83 (+1.09%) ▲|NKE36.89+0.27 (+0.74%) ▲|NOW131.74+0.57 (+0.43%) ▲|NVDA219.95+1.59 (+0.73%) ▲|ORCL153.28+0.34 (+0.22%) ▲|PEP136.71+0.06 (+0.04%) ▲|PFE27.44-0.22 (-0.78%) ▼|PG144.00+1.03 (+0.72%) ▲|PLTR166.84+0.98 (+0.59%) ▲|PM193.05+3.28 (+1.73%) ▲|QCOM184.30+7.42 (+4.19%) ▲|RTX197.50-0.62 (-0.31%) ▼|SBUX99.47+0.25 (+0.25%) ▲|SCHW106.44-0.89 (-0.83%) ▼|SO87.92+0.17 (+0.19%) ▲|SPG204.94+0.27 (+0.13%) ▲|T26.26+0.71 (+2.76%) ▲|TMO611.59+8.41 (+1.39%) ▲|TMUS183.07+5.91 (+3.34%) ▲|TSLA365.57+2.01 (+0.55%) ▲|TXN272.07+13.25 (+5.12%) ▲|UBER71.32-1.24 (-1.71%) ▼|UNH378.87-9.41 (-2.42%) ▼|UNP284.48-1.31 (-0.46%) ▼|UPS99.71-0.26 (-0.26%) ▼|USB62.69+0.28 (+0.44%) ▲|V370.08+2.87 (+0.78%) ▲|VZ50.68+0.71 (+1.42%) ▲|WFC90.27+0.82 (+0.92%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.53+0.30 (+0.18%) ▲|AAPL335.29+8.72 (+2.67%) ▲|ABBV256.43+1.43 (+0.56%) ▲|ABT101.74-1.62 (-1.57%) ▼|ACN180.17+2.26 (+1.27%) ▲|ADBE248.03-0.80 (-0.32%) ▼|AMAT463.70+9.69 (+2.13%) ▲|AMD517.08+13.48 (+2.68%) ▲|AMGN379.96-2.52 (-0.66%) ▼|AMT178.28+5.30 (+3.06%) ▲|AMZN255.90+4.01 (+1.59%) ▲|AVGO365.67+4.84 (+1.34%) ▲|AXP323.95+3.24 (+1.01%) ▲|BA209.03+4.23 (+2.07%) ▲|BAC62.77+0.21 (+0.34%) ▲|BKNG173.69-0.22 (-0.13%) ▼|BLK1,086.15+23.75 (+2.24%) ▲|BMY63.33-0.42 (-0.66%) ▼|BNY162.95+0.36 (+0.22%) ▲|BRK-B506.99-0.01 (0.00%) ▼|C138.49-0.01 (-0.01%) ▼|CAT821.43+16.43 (+2.04%) ▲|CL87.17-0.73 (-0.83%) ▼|CMCSA25.26+0.09 (+0.34%) ▲|COF207.32+0.21 (+0.10%) ▲|COP136.06-0.98 (-0.72%) ▼|COST903.31+0.93 (+0.10%) ▲|CRM248.33+5.33 (+2.19%) ▲|CSCO111.88+4.44 (+4.13%) ▲|CVS94.04-1.26 (-1.32%) ▼|CVX213.71+0.95 (+0.44%) ▲|DE685.84+7.90 (+1.17%) ▲|DHR200.47-0.07 (-0.03%) ▼|DIS106.92+1.10 (+1.04%) ▲|DUK119.38+0.01 (+0.01%) ▲|EMR150.99+2.62 (+1.77%) ▲|FDX311.14-0.66 (-0.21%) ▼|GD354.17-0.09 (-0.02%) ▼|GE323.91-0.25 (-0.08%) ▼|GEV951.57+27.66 (+2.99%) ▲|GILD143.66-1.15 (-0.79%) ▼|GM85.96-0.16 (-0.19%) ▼|GOOG338.74+8.35 (+2.53%) ▲|GOOGL341.70+9.10 (+2.74%) ▲|GS1,028.20+8.43 (+0.83%) ▲|HD309.33+3.64 (+1.19%) ▲|HON202.77+0.59 (+0.29%) ▲|IBM238.28+4.26 (+1.82%) ▲|INTC103.53+3.21 (+3.20%) ▲|INTU318.93+6.16 (+1.97%) ▲|ISRG367.64+7.18 (+1.99%) ▲|JNJ266.62+0.27 (+0.10%) ▲|JPM356.65+3.09 (+0.87%) ▲|KO88.00+0.17 (+0.19%) ▲|LIN464.70+3.08 (+0.67%) ▲|LLY1,120.39-2.62 (-0.23%) ▼|LMT524.42-5.71 (-1.08%) ▼|LOW197.49+0.90 (+0.46%) ▲|LRCX301.58+3.57 (+1.20%) ▲|MA567.37+2.00 (+0.35%) ▲|MCD252.95-0.10 (-0.04%) ▼|MDLZ62.27-0.20 (-0.32%) ▼|MDT90.38-1.24 (-1.35%) ▼|META653.25+8.87 (+1.38%) ▲|MMM163.88+1.02 (+0.62%) ▲|MO68.84+0.05 (+0.07%) ▲|MRK144.37-0.34 (-0.24%) ▼|MS213.45+0.79 (+0.37%) ▲|MSFT496.15+3.71 (+0.75%) ▲|MU978.44+1.03 (+0.11%) ▲|NEE82.37-0.07 (-0.08%) ▼|NFLX76.84+0.83 (+1.09%) ▲|NKE36.89+0.27 (+0.74%) ▲|NOW131.74+0.57 (+0.43%) ▲|NVDA219.95+1.59 (+0.73%) ▲|ORCL153.28+0.34 (+0.22%) ▲|PEP136.71+0.06 (+0.04%) ▲|PFE27.44-0.22 (-0.78%) ▼|PG144.00+1.03 (+0.72%) ▲|PLTR166.84+0.98 (+0.59%) ▲|PM193.05+3.28 (+1.73%) ▲|QCOM184.30+7.42 (+4.19%) ▲|RTX197.50-0.62 (-0.31%) ▼|SBUX99.47+0.25 (+0.25%) ▲|SCHW106.44-0.89 (-0.83%) ▼|SO87.92+0.17 (+0.19%) ▲|SPG204.94+0.27 (+0.13%) ▲|T26.26+0.71 (+2.76%) ▲|TMO611.59+8.41 (+1.39%) ▲|TMUS183.07+5.91 (+3.34%) ▲|TSLA365.57+2.01 (+0.55%) ▲|TXN272.07+13.25 (+5.12%) ▲|UBER71.32-1.24 (-1.71%) ▼|UNH378.87-9.41 (-2.42%) ▼|UNP284.48-1.31 (-0.46%) ▼|UPS99.71-0.26 (-0.26%) ▼|USB62.69+0.28 (+0.44%) ▲|V370.08+2.87 (+0.78%) ▲|VZ50.68+0.71 (+1.42%) ▲|WFC90.27+0.82 (+0.92%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.53+0.30 (+0.18%) ▲|
23.1 C
New York
Friday, September 11, 2026

Tag: meetings

newssourceFORcompanyinformationcontent1releasesmarket

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance’s pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.

Hermès International : Shares and voting rights as of 30th June 2025

RELEASE

HCLSoftware Launches Sovereign AI Aimed at Governments and Regulated Organizations Concerned with Their Data Privacy

NOIDA, India, July 10, 2025 /PRNewswire/ -- HCLSoftware, a global leader in enterprise software solutions, announced today the launch of HCL Domino 14.5. Specifically...

Jade Biosciences to Participate in Two Upcoming Investor Conferences

Jade Biosciences to Participate in Two Upcoming Investor Conferences

Medicines for Poland gibt bekannt: Ohne pharmazeutische Fabriken wird Europa jeden Krieg verlieren

BRÜSSEL, July 08, 2025 (GLOBE NEWSWIRE) -- Die Notwendigkeit, einen Fonds aus dem EU-Haushalt einzurichten, um die Produktion kritischer Arzneimittel in Europa zu unterstützen, ist eine Schlussfolgerung aus einer Analyse der Auswirkungen des Krieges auf die Verfügbarkeit von Arzneimitteln in der Ukraine. Medicines for Poland: Die Europäische Kommission sollte die bestehende Pharmaindustrie in Europa konkret unterstützen, um die Verlagerung der Produktion kritischer Arzneimittel und ihrer Inhaltsstoffe zurück in die EU zu ermöglichen, wobei der Schwerpunkt auf Mittel- und Osteuropa als Region mit hohem industriellem Potenzial liegen sollte.

Rich Folks Swap Cramped Seats for Private Wings

We’re 35,000 feet over the French Riviera, watching the sea sparkle like it’s showing off. Below, yachts are anchored, and I’m sipping champagne, which...

Hi & Fi Asia-China 2025 Shatters Records: Global Engagement Soars

SHANGHAI, July 8, 2025 /PRNewswire/ -- The 2025 edition of Hi & Fi Asia-China, held from24-26 June at NECC, Shanghai, concluded as its most impactful...

Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr., for Unilateral Vaccine Changes

AAP, ACP, APHA, IDSA, MPHA, and SMFM Join Together to Stop Assault on Public Health BOSTON, July 7, 2025 /PRNewswire/ -- Today, the American Academy...

PUDO Inc announces earnings call for Q1 FY 2026

TORONTO, July 7, 2025 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today announced that it will report its first...

REsimpli Launches Game-Changing AI-Powered CRM Tools for Real Estate Investors

Highland, Indiana, July 07, 2025 (GLOBE NEWSWIRE) -- REsimpli, a leading all-in-one AI CRM for Real Estate Investors, is thrilled to announce the launch of its REsimpli 5.0 release that introduces 8 powerful AI Agent tools and a List Pulling Feature that help investors pull off-market properties with necessary filters for the best results. These tools are designed to automate communication, reduce response times, and dramatically improve conversion rates.

Daughters of the American Revolution Celebrate National Award Winners at the 134th Continental Congress in Washington, DC

WASHINGTON, July 3, 2025 /PRNewswire/ -- Saturday, June 28 marked the final evening ceremony of the Daughters of the American Revolution (DAR) 134th Continental Congress...

CYMAT ANNOUNCES INVESTOR WEBINAR FOR MONDAY JULY 7 AT 11 AM

MISSISSAUGA, ON, July 3, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that Michael...

CYMAT ANNOUNCES INVESTOR WEBINAR FOR MONDAY JULY 7 AT 11 AM

MISSISSAUGA, ON, July 3, 2025 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that Michael...

Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson’s Disease and identifies clear opportunities...

ALTRINCHAM, England, July 3, 2025 /PRNewswire/ -- A new study is the first to examine the application of behavioural science in getting underused therapies...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMeetings

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers